Salmonella infection impacts host proteome thermal stability.

Bacterial pathogenesis Protein Thermal Stability Proteomics Salmonella T3SS effector

Journal

European journal of cell biology
ISSN: 1618-1298
Titre abrégé: Eur J Cell Biol
Pays: Germany
ID NLM: 7906240

Informations de publication

Date de publication:
06 Aug 2024
Historique:
received: 21 08 2023
revised: 31 07 2024
accepted: 03 08 2024
medline: 12 8 2024
pubmed: 12 8 2024
entrez: 11 8 2024
Statut: aheadofprint

Résumé

Intracellular bacterial pathogens hijack the protein machinery of infected host cells to evade their defenses and cultivate a favorable intracellular niche. The intracellular pathogen Salmonella enterica subsp. Typhimurium (STm) achieves this by injecting a cocktail of effector proteins into host cells that modify the activity of target host proteins. Yet, proteome-wide approaches to systematically map changes in host protein function during infection have remained challenging. Here we adapted a functional proteomics approach - Thermal-Proteome Profiling (TPP) - to systematically assess proteome-wide changes in host protein abundance and thermal stability throughout an STm infection cycle. By comparing macrophages treated with live or heat-killed STm, we observed that most host protein abundance changes occur independently of STm viability. In contrast, a large portion of host protein thermal stability changes were specific to infection with live STm. This included pronounced thermal stability changes in proteins linked to mitochondrial function (Acod1/Irg1, Cox6c, Samm50, Vdac1, and mitochondrial respiratory chain complex proteins), as well as the interferon-inducible protein with tetratricopeptide repeats, Ifit1. Integration of our TPP data with a publicly available STm-host protein-protein interaction database led us to discover that the secreted STm effector kinase, SteC, thermally destabilizes and phosphorylates the ribosomal preservation factor Serbp1. In summary, this work emphasizes the utility of measuring protein thermal stability during infection to accelerate the discovery of novel molecular interactions at the host-pathogen interface.

Identifiants

pubmed: 39128247
pii: S0171-9335(24)00065-7
doi: 10.1016/j.ejcb.2024.151448
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151448

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier GmbH.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Marlène S Birk (MS)

Institute of Medical Microbiology, RWTH University Hospital, Aachen 52074, Germany.

Philipp Walch (P)

European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Meyerhofstrasse 1, Heidelberg 69117, Germany.

Tarik Baykara (T)

Institute of Medical Microbiology, RWTH University Hospital, Aachen 52074, Germany.

Stephanie Sefried (S)

Institute of Medical Microbiology, RWTH University Hospital, Aachen 52074, Germany.

Jan Amelang (J)

Institute of Biochemistry and Molecular Biology, RWTH University Hospital, Aachen 52074, Germany.

Elena Buerova (E)

Institute of Biochemistry and Molecular Biology, RWTH University Hospital, Aachen 52074, Germany.

Ingrid Breuer (I)

Institute of Medical Microbiology, RWTH University Hospital, Aachen 52074, Germany.

Jörg Vervoots (J)

Institute of Biochemistry and Molecular Biology, RWTH University Hospital, Aachen 52074, Germany.

Athanasios Typas (A)

European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Meyerhofstrasse 1, Heidelberg 69117, Germany.

Mikhail M Savitski (MM)

European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Meyerhofstrasse 1, Heidelberg 69117, Germany.

André Mateus (A)

European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Meyerhofstrasse 1, Heidelberg 69117, Germany; Department of Chemistry, Umeå University, Umeå 907 36, Sweden; The Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå 907 36, Sweden. Electronic address: andre.mateus@umu.se.

Joel Selkrig (J)

Institute of Medical Microbiology, RWTH University Hospital, Aachen 52074, Germany; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Meyerhofstrasse 1, Heidelberg 69117, Germany. Electronic address: jselkrig@ukaachen.de.

Classifications MeSH